Vaxcyte (PCVX) Short Interest Ratio & Short Volume → “Crash Insurance” For Your Retirement (From Unstoppable Prosperity) (Ad) Free PCVX Stock Alerts $66.79 -0.73 (-1.08%) (As of 05/8/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Vaxcyte Short Interest DataCurrent Short Volume8,240,000 sharesPrevious Short Volume8,260,000 sharesChange Vs. Previous Month-0.24%Dollar Volume Sold Short$514.09 millionShort Interest Ratio / Days to Cover9.7Last Record DateApril 15, 2024Outstanding Shares108,410,000 sharesPercentage of Shares Shorted7.60%Today's Trading Volume467,620 sharesAverage Trading Volume812,633 sharesToday's Volume Vs. Average58% Short Selling Vaxcyte ? Sign up to receive the latest short interest report for Vaxcyte and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatPCVX Short Interest Over TimePCVX Days to Cover Over TimePCVX Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Vaxcyte Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20248,240,000 shares $514.09 million -0.2%N/A9.7 $62.39 3/31/20248,260,000 shares $564.24 million -3.8%N/A9.6 $68.31 3/15/20248,590,000 shares $598.72 million +1.5%N/A9.9 $69.70 2/29/20248,460,000 shares $624.52 million -20.6%N/A9.3 $73.82 2/15/202410,650,000 shares $798.86 million +19.7%N/A12.3 $75.01 1/31/20248,900,000 shares $635.64 million +6.5%N/A10.7 $71.42 Get the Latest News and Ratings for PCVX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaxcyte and its competitors with MarketBeat's FREE daily newsletter. 1/15/20248,360,000 shares $507.62 million +9.7%N/A12.4 $60.72 12/31/20237,620,000 shares $478.54 million +3.7%N/A11.6 $62.80 12/15/20237,350,000 shares $445.12 million +3.8%N/A11.6 $60.56 11/30/20237,080,000 shares $366.53 million -2.6%N/A11.5 $51.77 11/15/20237,270,000 shares $369.32 million -0.8%N/A12.6 $50.80 10/31/20237,330,000 shares $352.57 million +6.2%N/A12.7 $48.10 10/15/20236,900,000 shares $317.40 million -4.2%N/A12.8 $46.00 9/30/20237,200,000 shares $367.06 million -9.1%N/A13.5 $50.98 9/15/20237,920,000 shares $409.62 million +4.9%N/A14.9 $51.72 8/31/20237,550,000 shares $392.00 million -2.6%N/A13.9 $51.92 8/15/20237,750,000 shares $368.05 million +3.6%N/A13.6 $47.49 7/31/20237,480,000 shares $359.49 million -0.1%N/A12.3 $48.06 7/15/20237,490,000 shares $371.80 million +0.4%N/A10.2 $49.64 6/30/20237,460,000 shares $372.55 million +8.4%N/A8.1 $49.94 6/15/20236,880,000 shares $358.72 million -2.7%N/A7.2 $52.14 5/31/20237,070,000 shares $350.11 million +4.0%N/A7.5 $49.52 5/15/20236,800,000 shares $342.45 million +3.8%N/A7 $50.36 4/30/20236,550,000 shares $280.54 million -7.1%N/A7 $42.83 4/15/20237,050,000 shares $257.33 million +17.3%N/A8.1 $36.50 3/31/20236,010,000 shares $225.25 million +6.0%N/A8.8 $37.48 3/15/20235,670,000 shares $220.56 million +14.8%N/A8.3 $38.90 2/28/20234,940,000 shares $202.39 million +4.7%N/A7 $40.97 2/15/20234,720,000 shares $203.67 million +1.5%N/A6.6 $43.15 1/31/20234,650,000 shares $210.88 million +5.9%N/A6 $45.35 1/15/20234,390,000 shares $195.88 million -2.0%N/A3.3 $44.62 12/30/20224,480,000 shares $214.82 million +30.2%N/A3.4 $47.95 12/15/20223,440,000 shares $156.45 million +3.6%N/A2.6 $45.48 11/30/20223,320,000 shares $152.92 million -8.8%N/A2.7 $46.06 11/15/20223,640,000 shares $160.31 million -12.3%N/A3.1 $44.04 10/31/20224,150,000 shares $180.98 million +29.7%N/A3.7 $43.61 10/15/20223,200,000 shares $78.59 million +29.0%8.2%4.2 $24.56 9/30/20222,480,000 shares $59.52 million +22.8%6.3%5.7 $24.00 9/15/20222,020,000 shares $57.00 million +10.4%5.2%5.1 $28.22 8/31/20221,830,000 shares $47.87 million -12.9%4.7%4.8 $26.16“Crash Insurance” For Your Retirement (Ad)When it comes to retirement, everyone fears one thing… Outliving their retirement savings. You'll discover conservative, beginner-friendly options strategies which could help to cash flow your stock portfolio. Click here to register for free. PCVX Short Interest - Frequently Asked Questions What is Vaxcyte's current short interest? Short interest is the volume of Vaxcyte shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 8,240,000 shares of PCVX short. Learn More on Vaxcyte's current short interest. What is a good short interest ratio for Vaxcyte? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. PCVX shares currently have a short interest ratio of 10.0. Learn More on Vaxcyte's short interest ratio. Is Vaxcyte's short interest increasing or decreasing? Vaxcyte saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 8,240,000 shares, a decrease of 0.2% from the previous total of 8,260,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Vaxcyte's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Vaxcyte: Revolution Medicines, Inc. (7.33%), Exelixis, Inc. (3.01%), ImmunityBio, Inc. (40.05%), Halozyme Therapeutics, Inc. (6.55%), CRISPR Therapeutics AG (17.37%), Krystal Biotech, Inc. (8.59%), Repligen Co. (8.85%), Immunovant, Inc. (14.08%), Qiagen (1.34%), SpringWorks Therapeutics, Inc. (14.23%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Vaxcyte stock? Short selling PCVX is an investing strategy that aims to generate trading profit from Vaxcyte as its price is falling. PCVX shares are trading down $0.73 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vaxcyte? A short squeeze for Vaxcyte occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of PCVX, which in turn drives the price of the stock up even further. How often is Vaxcyte's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including PCVX, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: RVMD Short Interest EXEL Short Interest IBRX Short Interest HALO Short Interest CRSP Short Interest KRYS Short Interest RGEN Short Interest IMVT Short Interest QGEN Short Interest SWTX Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:PCVX) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityThe AI Stock that’s Disrupting Every IndustryStockEarningsShocking: One AI startup's revenue could surge 4,735%Manward Press